We showed that MIF primarily locates in the cytosol but is translocated to the nucleus when cancer cells enter S phase, which is supported by the previous clinical data showing that nuclear MIF protein is detected in a large number (79.7%) of human tumors including glioblastoma, bladder tumors, and lung adenocarcinoma48–50. Here, MIF is linked to glioblastoma.